Universal Labs is a private investor that is a qualified opportunity fund. The firm is interested in life sciences technology funds for companies that are dedicated to accelerating the commercialization of botanical and probiotic medicines. Companies that have demonstrated real world efficacy to prevent and treat chronic health conditions.
The firm looks to develop botanical medicines, targeted probiotics, and immunotherapy and cancer care treatments. The firm looks to make their breakthroughs affordable.